Jan 18 (Reuters) - Biosynex SA ALBIO.PA :
* FY REVENUE EUR 93.1 MILLION VERSUS EUR 196.6 MILLION YEAR
AGO
* IN 2024, THE GROUP EXPECTS TO SEE A RETURN TO GROWTH IN
ITS
OVERALL BUSINESS, WITH GROWTH IN BOTH FAMILY HEALTH AND
DIAGNOSTICS
* THE GROUP INTENDS TO FURTHER DEVELOP ITS INTERNATIONAL
SALES BY
DRAWING ON THE SALES FORCES OF ITS NEW SUBSIDIARIES
Source text for Eikon: ID:nEQ7vcV5Pa
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))